Royal Philips, a global health products company whose specialty areas include interventional cardiology, will now sell an imaging system made by Infraredx Inc., a Burlington-based medical device company with a focus on coronary artery disease, the two companies said.
Under the agreement, Philips will sell Infraredx’s TVC Imaging System alongside its Allura interventional X-ray systems in North America and Europe.
According to Infraredx, its TVC Imaging System integrates near-infrared spectroscopy lipid core plaque detection technology and enhanced intravascular ultrasound imaging to visualize the presence of plaques, quantify the degree of vessel narrowing, and identify plaques prone to rupturing and causing dangerous blockages.
In a statement, Don Southard, president and chief executive of Infraredx, said: “We’re pleased to partner with Philips, the leader in interventional X-ray systems, to expand access to our innovative TVC Imaging System among Philips’ broad and established customer base in North America and Europe. This resale agreement advances our global commercialization strategy by increasing our product’s penetration in the cardiac imaging market.”
Royal Philips is headquartered in the Netherlands. Its Philips Healthcare unit has 2,750 employees in Massachusetts.